Uruguay announced it will regulate the constitutional right to assembly when a sanitary emergency, lockdown access to the country from 21 December to 10 January, limit the number of passengers in long range transport, and have government staff take their annual vacation and those remaining, unless essential personnel, will work from their homes.
The Chilean health regulator has approved for emergency use the COVID-19 vaccine from Pfizer Inc and BioNTech SE, paving the way for the first doses to be administered as early as Christmas to citizens over the age of 16.
Argentina and the UK hosted a virtual seminar on access to vaccines in Latin America and the Caribbean addressing the portfolio of emerging vaccines against COVID-19, the challenge of equitable distribution and how best to tackle vaccine disinformation.
At least a fifth of the world's population may not have access to a COVID-19 vaccine until 2022, according to a study published on Wednesday, with wealthier nations reserving more than half of 2021's potential doses.
A quarter of Mexico's population, or 31 million people, has been exposed to COVID-19, according to preliminary results of an official survey, with 70% never showing symptoms.
Chancellor Angela Merkel banged the podium in frustration as she implored Germans this month to reduce social contacts to curb the spread of COVID-19. At one point in her unusually passionate address to parliament, during which she was heckled, she brought her hands together as if in prayer. At others, she shook her fist.
Argentina on Tuesday reported 6,981 new COVID-19 cases, bringing its national tally to 1,510,203, said the Ministry of Health. The ministry also said that 165 more patients died of the disease, raising the nationwide death toll to 41,204.
Moderna's vaccine is safe and effective for preventing Covid-19, US regulators said, clearing the way for a second shot to quickly gain emergency authorization and add to the country's sprawling immunization effort.
The government of President Jair Bolsonaro said that Brazil has guaranteed access to 300 million vaccines, mainly those developed by Oxford University along with AstraZeneca pharmaceutical and Brazil's Fiocruz foundation, as well as vaccines from the Covax Facility international initiative.
Brazil’s health regulator Anvisa said China’s health authorities are not transparent in their authorization of COVID-19 vaccines for emergency use, a statement that may further inflame political tension in the country.